Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Cancer Treatment Reviews
|
June 27, 2026
Precision targeting of CLDN18.2: A new therapeutic paradigm for gastric cancer
Wei Zhou, Wuxuan Mei, Changchun Zeng
Biochimica Et Biophysica Acta. Reviews on Cancer
|
March 5, 2022
Oncogenic Neuregulin 1 gene (NRG1) fusions in cancer: A potential new therapeutic opportunities
Congwang Zhang, Wuxuan Mei, Changchun Zeng
International Journal of Biological Macromolecules
|
April 12, 2024
Exploring FGFR signaling inhibition as a promising approach in breast cancer treatment
Yan Peng, Pengfei Zhang, Wuxuan Mei, et al.
Biochemistry and Biophysics Reports
|
October 8, 2024
Unveiling functionality and conducting two-sample mendelian randomization on WGCNA-identified oxidative stress-related hub genes in metabolic dysfunction-associated fatty liver disease
Qian Zhu, Jiaqi Liu, Wuxuan Mei, et al.
Frontiers in Immunology
|
January 31, 2024
Intratumoral microbiota: implications for cancer onset, progression, and therapy
Jinmei Wu, Pengfei Zhang, Wuxuan Mei, et al.
European Journal of Medicinal Chemistry
|
June 24, 2025
Current insights and barriers in FGFR-mediated signaling in lung cancer
Xiaohong Liu, Wuxuan Mei, Yueru Yao, et al.
Pharmacological Research
|
March 3, 2024
PIK3CA mutation as an acquired resistance driver to EGFR-TKIs in non-small cell lung cancer: Clinical challenges and opportunities
Xiaohong Liu, Wuxuan Mei, Pengfei Zhang, et al.
Cancer Treatment Reviews
|
May 19, 2024
Methylated circulating tumor DNA in hepatocellular carcinoma: A comprehensive analysis of biomarker potential and clinical implications
Qian Zhu, Jiaqi Xie, Wuxuan Mei, et al.
Frontiers in Oncology
|
December 6, 2021
Circulating Tumor DNA and Minimal Residual Disease (MRD) in Solid Tumors: Current Horizons and Future Perspectives
Yan Peng, Wuxuan Mei, Kaidong Ma, et al.
Current Treatment Options in Oncology
|
August 3, 2023
Combining Radiotherapy with Immunotherapy in Cervical Cancer: Where Do We Stand and Where Are We Going?
Yan Peng, Hongxiang Yan, Wuxuan Mei, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Cancer Treatment Reviews
|
June 27, 2026
Precision targeting of CLDN18.2: A new therapeutic paradigm for gastric cancer
Wei Zhou, Wuxuan Mei, Changchun Zeng
Biochimica Et Biophysica Acta. Reviews on Cancer
|
March 5, 2022
Oncogenic Neuregulin 1 gene (NRG1) fusions in cancer: A potential new therapeutic opportunities
Congwang Zhang, Wuxuan Mei, Changchun Zeng
International Journal of Biological Macromolecules
|
April 12, 2024
Exploring FGFR signaling inhibition as a promising approach in breast cancer treatment
Yan Peng, Pengfei Zhang, Wuxuan Mei, et al.
Biochemistry and Biophysics Reports
|
October 8, 2024
Unveiling functionality and conducting two-sample mendelian randomization on WGCNA-identified oxidative stress-related hub genes in metabolic dysfunction-associated fatty liver disease
Qian Zhu, Jiaqi Liu, Wuxuan Mei, et al.
Frontiers in Immunology
|
January 31, 2024
Intratumoral microbiota: implications for cancer onset, progression, and therapy
Jinmei Wu, Pengfei Zhang, Wuxuan Mei, et al.
European Journal of Medicinal Chemistry
|
June 24, 2025
Current insights and barriers in FGFR-mediated signaling in lung cancer
Xiaohong Liu, Wuxuan Mei, Yueru Yao, et al.
Pharmacological Research
|
March 3, 2024
PIK3CA mutation as an acquired resistance driver to EGFR-TKIs in non-small cell lung cancer: Clinical challenges and opportunities
Xiaohong Liu, Wuxuan Mei, Pengfei Zhang, et al.
Cancer Treatment Reviews
|
May 19, 2024
Methylated circulating tumor DNA in hepatocellular carcinoma: A comprehensive analysis of biomarker potential and clinical implications
Qian Zhu, Jiaqi Xie, Wuxuan Mei, et al.
Frontiers in Oncology
|
December 6, 2021
Circulating Tumor DNA and Minimal Residual Disease (MRD) in Solid Tumors: Current Horizons and Future Perspectives
Yan Peng, Wuxuan Mei, Kaidong Ma, et al.
Current Treatment Options in Oncology
|
August 3, 2023
Combining Radiotherapy with Immunotherapy in Cervical Cancer: Where Do We Stand and Where Are We Going?
Yan Peng, Hongxiang Yan, Wuxuan Mei, et al.
Page
of 2